BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 9
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 108748
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108748
Figure 3
Full Size Figure Download Figure
Figure 3 Management of type III gastric neuroendocrine tumors. This diagram shows the decision-making involved in management of the most aggressive subtype of gastric neuroendocrine tumors, type III. These pathways are adapted from the European Neuroendocrine Tumor Society 2023 Guidelines. This is an original figure. EUS: Endoscopic ultrasound; G-NET: Gastric neuroendocrine tumor.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.